Bespoke Extracts (BSPK) Total Non-Current Liabilities (2017 - 2018)
Bespoke Extracts' (BSPK) quarterly Total Non-Current Liabilities came in at $81153.0 in Q3 2018, down 57.99% year-on-year from $193163.0 in Q3 2017, and up 11.02% quarter-over-quarter from $73098.0 in Q2 2018.
Bespoke Extracts (BSPK) Total Non-Current Liabilities (2017 - 2018) Analysis & Trends
Bespoke Extracts has disclosed Total Non-Current Liabilities across 2 years of filings, most recently posting $81153.0 for Q3 2018.
- Total Non-Current Liabilities for Q3 2018 came in at $81153.0, down 57.99% year-over-year; the trailing twelve-month figure through Aug 2018 was $81153.0 (down 57.99% YoY), and the FY2018 annual result was $81153.0, down 57.99% from the prior year.
- Total Non-Current Liabilities came in at $81153.0 for Q3 2018 at Bespoke Extracts, up from $73098.0 in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $322893.0 in Q1 2018 to a low of $73098.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.81 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.13 Bn |
| 10 | Bespoke Extracts | - | - | 234,175.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2018 | 81,153.00 |
| May 31, 2018 | 73,098.00 |
| Feb 28, 2018 | 322,893.00 |
| Nov 30, 2017 | 279,494.00 |
| Aug 31, 2017 | 193,163.00 |